GMP,药品,药学,制药,新药,色谱,药品生产,中药,药材,原料药,医药,中间体,药用辅料

混粉验证PQ阶段是测试含量均匀度还是粒度分布均匀度呢?

时间: 2008-09-27 02:55:39 作者: 来源: 字号:
混粉验证PQ阶段是测试含量均匀度还是粒度分布均匀度呢?
好象先阶段都是 以含量均匀度的多点也有说服力,粒度分布 因为每次的颗粒大小有细微差别都会引起较大误差,所以取的少.
含量均匀度的标准是多少?RSD2%?
依据FDA 工业指南:“Powder Blends and Finished Dosage Units — Stratified In-Process Dosage Unit Sampling and Assessment”中所述,如下:

We recommend that during the manufacture of exhibit and process validation batches, you assess the uniformity of the powder blend, the in-process dosage units, and the finished product independently. We recommend you use the following steps to identify sampling locations and acceptance criteria prior to the manufacture of the exhibit and/or validation batches.
建议在工艺展示批次及工艺验证批次生产中,分别评价粉末混合均匀度、中控制剂单位以及终产品制剂单位均匀度。推荐使用以下步骤来确定取样方案和可接受限度:
1. Carefully identify at least 10 sampling locations in the blender to represent potential areas of poor blending. For example, in tumbling blenders (such as V-blenders, double cones, or drum mixers), samples should be selected from at least two depths along the axis of the blender. For convective blenders (such as a ribbon blender), a special effort should be made to implement uniform volumetric sampling to include the corners and discharge area (at least 20 locations are recommended to adequately validate convective blenders).
1.谨慎地在总混机中选定10个取样位置,必须能够代表最差混合区域。例如:在翻斗混合机(V-型,双锥型,或鼓型混合机),必须选择至少两个沿转轴的不同深度地取样点;······
2. Collect at least 3 replicate samples from each location. Samples should meet the following criteria:
2.在每个取样点至少取样3份。样品应符合以下标准:
. Assay target=_blank>Guidance for Industry.pdf (296.81k)
多谢楼上筒子,呵呵,我总是不会传附件,寒!
多谢wingzcw深度分析,但是我们指得是API的混粉工艺,而且含量均匀度确实是已经做了,但是几个国际大公司的QA来审计,还是提出考察粒度分布均匀度的要求?

还有其他相关指南吗?或者宝贵建议。

万分感谢
发表评论 共有条评论
验证码: 看不清楚,点击刷新 匿名发表